Microtubule Inhibitor [EPC]

22 drugs in this class with 1,138,396 total adverse event reports.

22 Drugs

1,138,396 Total Reports

568,905 Serious Reports

185,166 Death Reports

#	Drug Name	Generic Name	Reports	Serious	Deaths
1	Carboplatin	CARBOPLATIN	122,602	66,132	19,569
2	Bevacizumab	BEVACIZUMAB	120,853	52,978	27,863
3	Pembrolizumab	PEMBROLIZUMAB	100,428	73,843	18,175
4	Pegfilgrastim	PEGFILGRASTIM	97,462	33,650	5,224
5	Paclitaxel	PACLITAXEL	95,861	50,663	15,996
6	Paclitaxel (Aibumin-Bound)	PACLITAXEL (AIBUMIN-BOUND)	79,282	43,516	11,097
7	Fluorouracil	FLUOROURACIL	75,128	33,864	10,682
8	Fluorouracil Cream, 0.5%	FLUOROURACIL CREAM, 0.5%	74,062	33,499	10,606
9	Trastuzumab	TRASTUZUMAB	67,214	27,424	8,113
10	Docetaxel	DOCETAXEL	66,019	24,870	8,740
11	Gemcitabine	GEMCITABINE	38,203	19,294	7,242
12	Atezolizumab	ATEZOLIZUMAB	37,421	22,926	9,568
13	Cetuximab	CETUXIMAB	30,786	9,631	4,188
14	Pertuzumab	PERTUZUMAB	26,574	12,291	2,652
15	Olaparib	OLAPARIB	20,092	15,002	5,804
16	Durvalumab	DURVALUMAB	18,758	14,870	5,823
17	Lapatinib	LAPATINIB	15,403	3,382	2,460
18	Goserelin	GOSERELIN	13,080	6,297	2,389
19	Lutetium Lu 177 Vipivotide Tetraxetan	LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN	12,345	12,335	1,561
20	Erlotinib	ERLOTINIB	9,597	5,214	4,329
21	Gefitinib	GEFITINIB	8,949	2,778	1,949
22	Ado-Trastuzumab Emtansine	ADO-TRASTUZUMAB EMTANSINE	8,277	4,446	1,136